Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 60 2005 027 400.6 |
| 96 | EP file number | EAKZ | 05 78 4419.3 |
| 86 | WO file number | WAKZ | PCT/US2005/028186 |
| 97 | EP publication number | EPN | 1841781 |
| 87 | WO publication number | WPN | 2006073508 |
| 54 | Designation/title | TI | IL-22 ZUR BEHANDLUNG VON FETTLEIBIGKEIT, DIABETES, HYPERLIPIDÄMIE, HYPERGLYKÄMIE UND INSULINRESISTENZ |
| 51 | IPC main class | ICM
(ICMV) | C07K 1/00 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | C07K 14/54 (2006.01), A61K 38/00 (2006.01), A61K 38/20 (2006.01), A61P 3/04 (2006.01), A61P 3/06 (2006.01), A61P 3/10 (2006.01) |
| 22 | DE application date | DAT | Aug 8, 2005 |
| 96 | EP application date | EAT | Aug 8, 2005 |
| 86 | WO application date | WAT | Aug 8, 2005 |
| 43 | Date of first publication | OT | Jul 13, 2006 |
| Date of publication of grant | PET | Apr 6, 2011 |
| 71/73 | Applicant/owner | INH | Evive Biotechnology (Shanghai) Ltd., Shanghai, CN |
| 72 | Inventor | IN | HUANG, Yu, Liang, Carlsbad, CA 92009, US; CHEN, Xu, Wen, Carlsbad, CA 92009, US |
| Address for service | | Cabinet Chaillot, 92703 COLOMBES CEDEX, FR |
33
31
32
| Foreign priority | PRC
PRNA
PRDA
| CN
200510023103
Jan 4, 2005
|
| Due date | FT
FG | Aug 31, 2024
Annual fee for the 20th year
Patent fees |
| Patent division in charge | | 44 |
| 97 | EP language of publication | ELANG | EN - Englisch |
| 87 | WO language of publication | WLANG | EN - Englisch |
| 84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document: EP000001841781
Searchable text:
EP000001841781
Original document:
EP000001841781B1
Searchable text:
EP000001841781B1
Original document:
WO002006073508
Searchable text:
WO002006073508 |
| 43 | Date of first publication | EVT | Jul 13, 2006 |
| Date of the first transfer into DPMAregister | EREGT | Sep 30, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 5, 2023
(Show all update days)(Hide all update days)- Sep 5, 2023; Aug 27, 2022; Oct 7, 2021; Sep 1, 2021; Aug 28, 2021; Aug 31, 2020; Sep 5, 2019; Oct 19, 2018; Aug 31, 2018; Aug 29, 2017; Aug 27, 2016; Sep 12, 2015; Sep 9, 2014; Sep 10, 2013; Aug 7, 2013; Aug 1, 2013; Jan 31, 2013
- Historical data not available for this/these date(s)
- Sep 30, 2012
- Date of the first transfer into DPMAregister
|
Procedural data| No. |
Kind of procedure
|
Legal status
|
Date of legal/procedural status
 |
Date of first publication
| Display all details |
|---|
| 1 |
Procedure relating to PCT application
|
WO first publication without search report
|
Jul 13, 2006
| |
Display details
|
| 2 |
Procedure relating to EP application
|
EPO 1st publication
|
Oct 10, 2007
| |
Display details
|
| 3 |
Procedure relating to EP application
|
EPO publication of search report
|
Oct 10, 2007
| |
Display details
|
| 4 |
Publications
|
Publication of a mention regarding EP 1st publication by DPMA
|
Nov 22, 2007
|
Nov 22, 2007 |
Display details
|
| 5 |
New applicant/owner details
|
New applicant/owner details
|
Mar 10, 2011
|
Oct 7, 2021 |
Display details
|
| 6 |
Procedure relating to EP application
|
EPO publication of mention regarding patent grant (beginning of opposition period)
|
Apr 6, 2011
| |
Display details
|
| 7 |
Publications
|
Publication by DPMA of mention regarding EP patent grant
|
May 19, 2011
|
May 19, 2011 |
Display details
|
| 8 |
Procedure relating to EP application
|
No opposition to patent grant filed, or opposition proceedings at EPO completed without decision
|
Jan 10, 2012
|
May 3, 2012 |
Display details
|
| 9 |
New applicant/owner details
|
New applicant/owner details
|
Aug 31, 2021
|
Oct 7, 2021 |
Display details
|
